Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

33.84

+0.04 (0.12%)

as of Jun 19, 2026, 8:00:01 pm Market Open.

136 watching

PAST TOP PICK

(A Top Pick Dec 22/06. Up 24.7%.) Still likes, but wouldn't add at these levels.

PAST TOP PICK

(A Top Pick Nov 21/06. Up 7.4%.) Likes the acquisition metrics. Skilled nursing/long-term care facilities can be acquired at 10 or 12 cash flow yield whereas cost of capital is about 6.5%-7% range. Very low debt.

TOP PICK

Seniors’ housing. In the US they focus on skilled nursing facilities and in Canada on long-term care facilities. Recently spun out Assisted Living (ALC-N) and will spin out Crown, hopefully early in the new year. Under $15.50 it is definitely a strong Buy.

WEAK BUY

Spin off from Assisted Living Concepts (ALC-N) in the US. 7.4% yield. Trying to establish a base. Expect to gradually improve, but no huge returns for now.

TOP PICK

Seniors housing space. Peers operate at 50/60% leverage to book value of assets. They are at 30/40%, which means they will be able to acquire properties largely with debt and very little cost of capital, but high tax flow yields on property. And external acquisition story.

PAST TOP PICK

(A Top Pick July 21/06. Up 8.3%.) (Now a trust.) Is not getting the exemptions that some REITs are, otherwise it would be a lot higher. Consider selling your shares.

BUY

Stock has done exceptionally well. Positive free cash flow and is considering converting to a trust. Debt to EBIDTA is only .4 Xs. Very clean balance sheet.

TOP PICK

Splitting into 2 companies, one of them an income trust. An excellent risk/reward.

BUY

A major nursing home operator in North America. 80% of the earnings come from the US. Converting to in income trust which could result in a $28/29 price. Have one of the best franchises in the business. Occupancy rates are very good. Margins are high.

SELL

It looks like the company was put up for auction, but nobody is stopping up to buy it. Would look elsewhere are if you're interested in the healthcare sector.

DON'T BUY

They are doing a strategic review which basically means selling the company. If you own the stock, sell half of it keep half and see what happens. Don't buy.

DON'T BUY

Worries about this industry because of government intervention. Nothing wrong with the fundamental model, but we live in a place where seniors have a lot of political sway and worried about government getting into this industry.

BUY

A first rate company. Looking at it 2/3 years, the demographics are right. They have executed their business plan very well. Good long-term hold.

BUY

The demographics for longer-term care are really good.

WEAK BUY

Might still have some upside. Up 440% in last year.

Showing 181 to 195 of 230 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Extendicare Inc (EXE.TO)